Rezolute, Inc.
USD4.45
-0.16 (-3.47%)
CEO
Nevan Charles Elam
IPO Date
2013-01-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.65
Prev. Close
$4.61
Day Low
$4.39
Day High
$4.71
52W Low
$1.07
52W High
$11.46
Market Cap
$0.43B
Volume
1.27M
| 8,004 |
| $4.99 |
| 7 Jul 2026 | Evans Daron | CFO | F-InKind | Disposed | 3,062 | $4.99 |
| 31 Mar 2026 | Evans Daron | CFO | P-Purchase | Acquired | 10,000 | $2.85 |
| 4 Mar 2026 | ROBERTS BRIAN KENNETH | Chief Medical Officer | F-InKind | Disposed | 11,439 | $2.99 |
| 4 Mar 2026 | Evans Daron | CFO | F-InKind | Disposed | 11,438 | $2.99 |
| 4 Mar 2026 | Elam Nevan C | director, officer: CEO | F-InKind | Disposed | 27,618 | $2.99 |
| 17 Dec 2025 | Hogenhuis Wladimir | director | P-Purchase | Acquired | 5,650 | $1.69 |
| 17 Dec 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P-Purchase | Acquired | 28,000 | $1.70 |
| 15 Dec 2025 | Evans Daron | CFO | P-Purchase | Acquired | 40,000 | $1.77 |